Antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2 Grant US-12030927-B2 United States of America 09 Jul 2024
Antigen binding molecules targeting SARS-CoV-2 Grant US-11993644-B2 United States of America 28 May 2024
Antigen binding molecules targeting SARS-CoV-2 Grant US-11987616-B2 United States of America 21 May 2024
Antigen binding molecules targeting SARS-CoV-2 Grant US-11981725-B2 United States of America 14 May 2024
3D PRINTED GENE-ACTIVATED SCAFFOLDS FOR BONE REGENERATION Application WO-2024091971-A1 World Intellectual Property Organisation (WIPO) 02 May 2024
INFLUENZA VIRUS VACCINES Application WO-2024068545-A1 World Intellectual Property Organisation (WIPO) 04 Apr 2024
USES OF GLYCOLIPIDS AS A VACCINE ADJUVANT AND METHODS THEREOF Application WO-2023240278-A3 World Intellectual Property Organisation (WIPO) 15 Feb 2024
ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF Application WO-2024018205-A1 World Intellectual Property Organisation (WIPO) 25 Jan 2024
IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE Application WO-2024011033-A1 World Intellectual Property Organisation (WIPO) 11 Jan 2024
COMPOSITIONS AND METHODS FOR PREPARING CAPPED CIRCULAR RNA MOLECULES Application WO-2023250528-A1 World Intellectual Property Organisation (WIPO) 28 Dec 2023
METHOD FOR IN VITRO EVALUATION OF THE IMMUNE RESPONSE AFTER VACCINATION WITH A MRNA… Application WO-2023228225-A1 World Intellectual Property Organisation (WIPO) 30 Nov 2023
Treatment or prevention of diseases and disorders associated with cells that express IL-6… Grant US-11827700-B2 United States of America 28 Nov 2023
REAGENTS AND METHODS FOR PREPARING DERIVATIZED RNA MOLECULES AND METHODS OF USE THEREOF Application WO-2023225660-A1 World Intellectual Property Organisation (WIPO) 23 Nov 2023
SYNTHETIC SELF-AMPLIFYING MRNA MOLECULES WITH SECRETION ANTIGEN AND IMMUNOMODULATOR Application WO-2023220693-A1 World Intellectual Property Organisation (WIPO) 16 Nov 2023
ANTIBODIES AGAINST CHEMOKINES, METHOD FOR IDENTIFYING SAID ANTIBODIES AND USES THEREOF Application WO-2023213400-A1 World Intellectual Property Organisation (WIPO) 09 Nov 2023
ANTIBODIES AGAINST CHEMOKINES, METHOD FOR IDENTIFYING SAID ANTIBODIES AND USES THEREOF Application WO-2023213911-A2 World Intellectual Property Organisation (WIPO) 09 Nov 2023
VACCINE COMPOSITION Application WO-2023194699-A2 World Intellectual Property Organisation (WIPO) 12 Oct 2023
COMPOSITIONS AND METHODS FOR ADJUVANTED VACCINES Application WO-2023183945-A1 World Intellectual Property Organisation (WIPO) 28 Sep 2023
Coronavirus vaccine compositions and methods Grant US-11744887-B2 United States of America 05 Sep 2023
ANALYSIS OF RNA MOLECULES USING CATALYTIC NUCLEIC ACIDS Application WO-2023139170-A1 World Intellectual Property Organisation (WIPO) 27 Jul 2023
ANALYSIS OF RNA MOLECULES USING CATALYTIC NUCLEIC ACIDS Application WO-2023138786-A1 World Intellectual Property Organisation (WIPO) 27 Jul 2023
IONIZABLE LIPIDS AND COMPOSITIONS AND USES THEREOF Application WO-2023114188-A1 World Intellectual Property Organisation (WIPO) 22 Jun 2023
ANTIGENIC DETERMINANTS, PROTECTIVE IMMUNITY, SERODIAGNOSTIC AND MULTIVALENT SUBUNITS… Application WO-2023094885-A2 World Intellectual Property Organisation (WIPO) 01 Jun 2023
UNIVERSAL SARBECOVIRUS VACCINES Application WO-2023088968-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
LIPID NANOPARTICLES FOR DRUG DELIVERY TO MICROGLIA IN THE BRAIN Application WO-2023059806-A1 World Intellectual Property Organisation (WIPO) 13 Apr 2023
CORONAVIRUS VACCINES Application WO-2023057769-A1 World Intellectual Property Organisation (WIPO) 13 Apr 2023
Lipid nanoparticle compositions and methods of formulating the same Grant US-11622972-B2 United States of America 11 Apr 2023
METHODS AND KIT FOR DETERMINING THE ANTIBODY STATUS AND T-CELL IMMUNITY AGAINST SARS-COV-2 Application WO-2023031437-A1 World Intellectual Property Organisation (WIPO) 09 Mar 2023
METHODS AND KIT FOR DETERMINING THE ANTIBODY STATUS AND T-CELL IMMUNITY AGAINST SARS-COV-2 Application EP-4145132-A1 European Patent Office 08 Mar 2023
LYOPHILISED FORMULATIONS OF mRNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES Application WO-2023026301-A1 World Intellectual Property Organisation (WIPO) 02 Mar 2023
Viral vaccine vector for immunization against betacoronavirus Application KR-20230016193-A Republic of Korea 01 Feb 2023
RNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES AND ITS FORMULATIONS. Application WO-2023286076-A1 World Intellectual Property Organisation (WIPO) 19 Jan 2023
BETA-CORONAVIRUS VACCINES Application WO-2023275538-A1 World Intellectual Property Organisation (WIPO) 05 Jan 2023
Lipid nanoparticle compositions and methods of formulating the same Grant US-11524023-B2 United States of America 13 Dec 2022
CONSTRUCTS AND METHODS FOR PREPARING CIRCULAR RNAS AND USE THEREOF Application WO-2022247943-A1 World Intellectual Property Organisation (WIPO) 01 Dec 2022
CORONAVIRUS VACCINE SUITABLE FOR ELDERLY INDIVIDUALS Application WO-2022244831-A1 World Intellectual Property Organisation (WIPO) 24 Nov 2022
NUCLEIC ACID MOLECULES AND VACCINES COMPRISING SAME FOR THE PREVENTION AND TREATMENT OF… Application WO-2022192594-A3 World Intellectual Property Organisation (WIPO) 24 Nov 2022
MODIFIED MRNA, MODIFIED NON-CODING RNA, AND USES THEREOF Application WO-2022241045-A1 World Intellectual Property Organisation (WIPO) 17 Nov 2022
IMMUNOGENIC COMPOSITION AGAINST INFLUENZA Application WO-2022234417-A1 World Intellectual Property Organisation (WIPO) 10 Nov 2022
THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER… Application WO-2022229461-A1 World Intellectual Property Organisation (WIPO) 03 Nov 2022
INDUCTION OF IMMUNITY TO SARS-COV-2 IN CHILDREN Application WO-2022197209-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2022
ANTIBODIES CONJUGATED OR FUSED TO THE RECEPTOR-BINDING DOMAIN OF THE SARS-COV-2 SPIKE… Application WO-2022101302-A1 World Intellectual Property Organisation (WIPO) 19 May 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086364-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086365-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
NUCLEIC ACID LIPID PARTICLE VACCINE Application WO-2021251453-A1 World Intellectual Property Organisation (WIPO) 16 Dec 2021
VIRAL VACCINE VECTOR FOR IMMUNIZATION AGAINST A BETACORONAVIRUS Application WO-2021233989-A1 World Intellectual Property Organisation (WIPO) 25 Nov 2021
NUCLEIC ACID VACCINES FOR CORONAVIRUS Application WO-2021204179-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021
USE OF ANTI-IL-6 ANTIBODY, E.G., CLAZAKIZUMAB FOR TREATMENT/PREVENTION OF ARDS ASSOCIATED… Application WO-2021188727-A1 World Intellectual Property Organisation (WIPO) 23 Sep 2021